Popular Articles
Burdock Root

Top Hospitals For Women's Health/Maternity Care Have Lower Mortality/Morbidity: HealthGrades Study
Wide gaps in quality outcomes for women persist, not only when compared to men, but among hospitals and states, according to a new study released by HealthGrades, the leading independent healthcare ratings organization. The Sixth Annual HealthGrades Women"s Health in American Hospitals study identifies patient outcomes for maternity care and inhospital treatment of 16 procedures/diagnoses concerning women"s health. Ratings for individual hospitals have been posted at www.healthgrades.com.
generic viagra online
Full Senate To Begin Debate On Sotomayor Tuesday
The full Senate on Tuesday is set to begin debate on Supreme Court nominee Sonia Sotomayor, who is widely expected to be confirmed by the end of the week, the Los Angeles Times reports (Savage/Oliphant, Los Angeles Times, 8/4).Six Republicans have announced that they will vote to confirm Sotomayor, while most are aligning with the party base to vote against her confirmation. No Democrats have announced that they will oppose her nomination. At the risk of alienating his state"s large Hispanic population, Sen. John McCain (R-Ariz.) on Monday announced that he will oppose Sotomayor"s confirmation (AP/USA Today, 8/4). "An excellent resume and an inspiring life story are not enough to quality oneself for a lifetime of service on the Supreme Court," McCain said, adding, "I do not believe she shares my belief in judicial restraint" (Los Angeles Times, 8/4). Sen. Ben Nelson (D-Neb.), an advocate for gun-rights, had been under pressure to vote against her but on Monday said that he supports the nominee and will vote to confirm her. Nelson said that he believes Sotomayor has "a great respect for the law" (AP/USA Today, 8/4).
News of the day
VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published In SCIENCE
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced that scientists reporting in the July 31 issue of SCIENCE have discovered a key disease-related biologic pathway using an integrated and innovative array of in vitro readouts and advanced in vivo imaging technologies. The newly reported biologic pathway relates to monocyte deployment from the spleen to inflammatory sites, including myocardial infarction. The findings are expected to open up new areas of research and potentially advance therapeutic approaches to key disease areas including inflammation and myocardial injury.
Nutrition

FDA Warns Web Sites Against Marketing Fraudulent H1N1 Flu Virus Claims

The U.S. Food and Drug Administration is enforcing the laws that protect consumers from illegal products marketed through the Internet that claim to diagnose, prevent, mitigate, treat or cure the 2009 H1N1 flu virus. On May 1, 2009, the FDA warned consumers regarding products related to the 2009 H1N1 flu virus offered on the Internet. The products involved are those that are promoted and marketed to diagnose, mitigate, prevent, treat, or cure the 2009 H1N1 flu virus but are not approved, cleared, or authorized by the FDA. The agency advised operators of offending Web sites that they must take immediate action to ensure that they are not marketing products intended to diagnose, mitigate, prevent, treat, or cure the 2009 H1N1 flu virus that have not been cleared, approved, or authorized by the FDA. Since then, the FDA has issued more than 50 warning letters to offending Web sites and as a result, more than 66 percent of these Web sites have removed the offending claims and/or products. "We are committed to aggressively pursuing those who attempt to take advantage of a public health emergency by promoting and marketing unapproved, uncleared, or unauthorized products," said Margaret A. Hamburg, M.D., Commissioner of Food and Drugs. "We have achieved some success and will remain vigilant in our efforts to protect consumers from these fraudulent, potentially dangerous products." Examples of unapproved, uncleared, or unauthorized products targeted by the FDA include: --A shampoo that claimed to protect against the H1N1 flu virus; --A dietary supplement that claimed to protect infants and young children from contracting the H1N1 flu virus; --A "new" supplement that claimed to cure H1N1 flu infection within four to eight hours; --A spray that claimed to leave a layer of ionic silver on one"s hands that killed the virus; --Several tests that have not been approved to detect the H1N1 flu virus; and --An electronic instrument costing thousands of dollars that claimed to utilize "photobiotic energy" and "deeply penetrating mega-frequency life-force energy waves" to strengthen the immune system and prevent symptoms associated with H1N1 viral infection. The FDA"s warning letters are consistent with an aggressive strategy the agency put into place to protect consumers from individuals or businesses that promote fraudulent claims for products in an attempt to take advantage of the public"s concerns about the 2009 H1N1 flu virus. Unapproved, uncleared, or unauthorized products that claim to diagnose, mitigate, prevent, treat or cure the 2009 H1N1 flu are illegal and a potentially significant threat to the public health. These warning letters were the result of daily Internet surfs conducted by the FDA"s Office of Enforcement, Office of Criminal Investigations, and staff from the Center for Devices and Radiological Health, the Center for Drug Evaluation and Research, and the Center for Food Safety and Applied Nutrition. The warning letters issued by e-mail and the FDA requested a response within 48 hours. In addition, the FDA posted the offending Web sites and products on the agency"s Web site. "Taking swift action to inform unsuspecting consumers about products that could be dangerous to their health is a major priority for the FDA," said Hamburg. The FDA will consider further civil or criminal enforcement action against those Web sites that fail to resolve the violations cited in warning letters. Actions could include seizure, injunction, and criminal prosecution. For more information: FDA"s Fraudulent H1N1 Flu Virus Product List Browse Warning Letters for: Unapproved/Uncleared/Unauthorized Products Related to the H1N1 Flu Virus Report Suspected Fraudulent Products or Criminal Activity Associated with H1N1 Flu Virus (Swine Flu) U.S. Food and Drug Administration


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):